Please login to the form below

Not currently logged in
Email:
Password:

apceth names Ulrike Verzetnitsch as chief technical officer

She joins from Takeda, with immediate effect

edit-apceth-Ulrike-VerzetnischCell therapy company apceth has appointed Ulrike Verzetnitsch in the newly created role of chief technical officer.

In the position, Verzetnitsch will lead apceth's production facilities and operations and continue the expansion of its fee-for-service GMP manufacturing business.

Commenting on the appointment, Christine Guenther, CEO of apceth, said: “apceth has recently started phase II of the world's first clinical trial with genetically modified mesenchymal stem cells in cancer indications and is simultaneously increasing its manufacturing capacity and capabilities as a CMO. It is therefore a very exciting time for us to welcome Ulrike to the team.

“Her experience will complement our management team and help drive apceth forward.”

She joins from Takeda, where she was head of the production unit based in Singen, Germany. Prior to that, Verzetnitsch held the role of director of production at Baxter, where she focused on strategic tasks in the final container operation of vaccines and plasma-based and recombinant products.

As part of her role, she gained experience in the manufacturing of products for worldwide distribution in compliance with the FDA, EMEA, Japanese and other guidelines.

28th April 2015

From: Research

Share

Tags

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
BOLDSCIENCE

We know what it takes to create brands, to start new conversations, to simply communicate complex science, to change lives…...

Latest intelligence

Covid-19 redefines rules of customer engagement
Oli Hudson, Content Director at Wilmington Healthcare, explores how the pandemic has changed pharma’s relationship with HCPs...
Ongoing Virtual Communication between MSLs and Physicians: a Customer Story
Learn how one of our clients used the Impetus InSite Platform to connect their MSLs with regional groups of physicians....
The concordance conundrum: understanding the complexities of behaviour change
Understanding behaviour change looks at the six fundamental steps required to change human behaviour and discusses why HCPs need to start here if concordance is to be improved....

Infographics